The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications

BACKGROUND: Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidates that have the highest chance of successfully being adopted in the clinic. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graaf, Gimon, Postmus, Douwe, Westerink, Jan, Buskens, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006586/
https://www.ncbi.nlm.nih.gov/pubmed/29946228
http://dx.doi.org/10.1186/s12962-018-0105-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006586/
https://www.ncbi.nlm.nih.gov/pubmed/29946228
http://dx.doi.org/10.1186/s12962-018-0105-z

Ejemplares similares